QuantumBio
QuantumBio, based in State College, US, develops innovative drug discovery software for the life science industry.
Founded
2002QuantumBio, based in State College, US, develops innovative drug discovery software for the life science industry.
QuantumBio, based in State College, US, was founded with the core mission of advancing drug discovery through innovative software solutions. The company focuses on providing cutting-edge technology services for the life science industry, specifically in structural biology and computer-aided drug design. Their products include software that refines X-ray crystallography structures and facilitates rapid, accurate drug discovery and development. QuantumBio aims to enhance the precision and efficiency of drug design processes, targeting pharmaceutical companies and research institutions.
Notable figures affiliated with QuantumBio include experts in computational chemistry and structural biology, although specific names are not provided. The company has achieved significant milestones in developing high-throughput drug design software, which has been adopted by various industry leaders. QuantumBio's impact lies in its ability to streamline the drug discovery process, leading to more accurate predictions and potentially faster development of new therapeutics.
Companies similar to QuantumBio include Polarisqb, Drug Design Methodologies, PathDrugomics and Biosim.
QuantumBio was founded in 2002.
QuantumBio's headquarters is located in State College, PA, US.
QuantumBio's most recent funding round was for $425k (USD) in June 2005.
As of Jun 23, 2005, QuantumBio has disclosed funding of $425k (USD). Undisclosed round amounts are excluded.
QuantumBio has 14 employees as of Feb 4, 2024.
Biosim
